CD40LG and COVID-19: Another FDA-approved POC test, a rapid IgM–IgG-combined antibody test for COVID-19, developed by Biomedomics (Becton Dickinson) can detect antiviral antibodies with 88.7% sensitivity and 90.6% specificity within 10–15 min [113].